Suppr超能文献

原发性皮肤鳞状细胞癌不良结局的患者风险因素、肿瘤特征和治疗方式的相关性:系统评价和荟萃分析。

Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.

机构信息

The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York.

出版信息

JAMA Dermatol. 2023 Feb 1;159(2):160-171. doi: 10.1001/jamadermatol.2022.5508.

Abstract

IMPORTANCE

Primary cutaneous squamous cell carcinoma is usually curable; however, a subset of patients develops poor outcomes, including local recurrence, nodal metastasis, distant metastasis, and disease-specific death.

OBJECTIVES

To evaluate all evidence-based reports of patient risk factors and tumor characteristics associated with poor outcomes in primary cutaneous squamous cell carcinoma and to identify treatment modalities that minimize poor outcomes.

DATA SOURCES

PubMed, Embase, and SCOPUS databases were searched for studies of the topic in humans, published in the English language, from database inception through February 8, 2022.

STUDY SELECTION

Two authors independently screened the identified articles and included those that were original research with a sample size of 10 patients or more and that assessed risk factors and/or treatment modalities associated with poor outcomes among patients with primary cutaneous squamous cell carcinoma.

DATA EXTRACTION AND SYNTHESIS

Data extraction was performed by a single author, per international guidelines. The search terms, study objectives, and protocol methods were defined before study initiation. A total of 310 studies were included for full-text assessment. Owing to heterogeneity of the included studies, a random-effects model was used. Data analyses were performed from May 25 to September 15, 2022.

MAIN OUTCOMES AND MEASURES

For studies of risk factors, risk ratios and incidence proportions; and for treatment studies, incidence proportions.

RESULTS

In all, 129 studies and a total of 137 449 patients with primary cutaneous squamous cell carcinoma and 126 553 tumors were included in the meta-analysis. Several patient risk factors and tumor characteristics were associated with local recurrence, nodal metastasis, distant metastasis, disease-specific death, and all-cause death were identified. Among all factors reported by more than 1 study, the highest risks for local recurrence and disease-specific death were associated with tumor invasion beyond subcutaneous fat (risk ratio, 9.1 [95% CI, 2.8-29.2] and 10.4 [95% CI, 3.0- 36.3], respectively), and the highest risk of any metastasis was associated with perineural invasion (risk ratio, 5.0; 95% CI, 2.3-11.1). Patients who received Mohs micrographic surgery had the lowest incidence of nearly all poor outcomes; however, in some results, the 95% CIs overlapped with those of other treatment modalities.

CONCLUSIONS AND RELEVANCE

This meta-analysis identified the prognostic value of several risk factors and the effectiveness of the available treatment modalities. These findings carry important implications for the prognostication, workup, treatment, and follow-up of patients with primary cutaneous squamous cell carcinoma.

TRIAL REGISTRATION

PROSPERO Identifier: CRD42022311250.

摘要

重要性

原发性皮肤鳞状细胞癌通常是可治愈的;然而,一部分患者会出现不良预后,包括局部复发、淋巴结转移、远处转移和疾病特异性死亡。

目的

评估所有与原发性皮肤鳞状细胞癌不良预后相关的基于证据的患者风险因素和肿瘤特征的报告,并确定能最大限度减少不良预后的治疗方法。

数据来源

在人类研究中,从数据库建立到 2022 年 2 月 8 日,通过 PubMed、Embase 和 SCOPUS 数据库搜索了关于该主题的所有英文发表的基于证据的报告。

研究选择

两位作者独立筛选了确定的文章,并纳入了样本量为 10 例或更多且评估了原发性皮肤鳞状细胞癌患者不良预后相关风险因素和/或治疗方法的原始研究。

数据提取和综合

根据国际指南,由一位作者进行数据提取。在研究开始前,定义了搜索词、研究目标和方案方法。共有 310 项研究被纳入全文评估。由于纳入研究的异质性,使用了随机效应模型。数据分析于 2022 年 5 月 25 日至 9 月 15 日进行。

主要结果和措施

对于风险因素研究,使用风险比和发病率比例;对于治疗研究,使用发病率比例。

结果

总共纳入了 129 项研究和总共 137449 例原发性皮肤鳞状细胞癌患者和 126553 例肿瘤的meta 分析。确定了几个与局部复发、淋巴结转移、远处转移、疾病特异性死亡和全因死亡相关的患者风险因素和肿瘤特征。在所有报告超过 1 项研究的因素中,与肿瘤侵犯皮下脂肪有关的局部复发和疾病特异性死亡的风险最高(风险比,9.1[95%CI,2.8-29.2]和 10.4[95%CI,3.0-36.3]),与任何转移相关的最高风险与神经周围侵犯有关(风险比,5.0;95%CI,2.3-11.1)。接受 Mohs 显微外科手术的患者几乎所有不良预后的发生率最低;然而,在某些结果中,95%CI 与其他治疗方法的 95%CI 重叠。

结论和相关性

这项 meta 分析确定了几个风险因素的预后价值和现有治疗方法的有效性。这些发现对原发性皮肤鳞状细胞癌患者的预后、检查、治疗和随访具有重要意义。

试验注册

PROSPERO 标识符:CRD42022311250。

相似文献

7
Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study.
JAMA Dermatol. 2013 Jan;149(1):35-41. doi: 10.1001/jamadermatol.2013.746.
8
Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
J Am Acad Dermatol. 2020 May;82(5):1195-1204. doi: 10.1016/j.jaad.2019.12.049. Epub 2019 Dec 27.
9
Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone.
J Am Acad Dermatol. 2019 Mar;80(3):633-638. doi: 10.1016/j.jaad.2018.09.015. Epub 2018 Sep 20.

引用本文的文献

2
A Comprehensive Narrative Review of the Challenges Surrounding Cutaneous SCC.
Dermatol Ther (Heidelb). 2025 Jun 23. doi: 10.1007/s13555-025-01470-7.
9
Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile.
Future Oncol. 2024;20(35):2737-2746. doi: 10.1080/14796694.2024.2390820. Epub 2024 Sep 4.
10
Polysemous terms need context: A case of poorly differentiated spindle cell cutaneous squamous cell carcinoma.
JAAD Case Rep. 2024 May 21;49:117-120. doi: 10.1016/j.jdcr.2024.04.046. eCollection 2024 Jul.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验